EXEL vs BBIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 15, 2026
EXEL
61.0
AI Score
VS
It's a Tie!
BBIO
61.0
AI Score
Investment Advisor Scores
BBIO
61score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | EXEL | BBIO | Winner |
|---|---|---|---|
| Revenue | 194.51M | 610.81M | EXEL |
| Net Income | -166.56M | 210.47M | EXEL |
| Net Margin | -85.6% | 34.5% | EXEL |
| Operating Income | -105.96M | 251.34M | EXEL |
| ROE | 7.3% | 10.9% | EXEL |
| ROA | -12.1% | 8.1% | EXEL |
| Total Assets | 1.37B | 2.59B | EXEL |
| Cash | 879.89M | 226.15M | BBIO |
| Current Ratio | 1.52 | 3.26 | EXEL |
| Free Cash Flow | -197.35M | 250.34M | EXEL |
Frequently Asked Questions
Based on our detailed analysis, EXEL and BBIO are evenly matched, both winning 9 key financial metrics each. This is a close call that depends on your specific investment goals.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.